Show notes
AI is designing drugs in months—not years. But the real bottleneck? Clinical validation.In this special episode of Below the Fold—recorded live at the Dubai AI Festival—Dr. Alex Aliper, CEO & President of Insilico Medicine, breaks down the final frontier in AI-powered drug discovery.From lab automation to quantum breakthroughs, Alex shares how AI is transforming every layer of pharmaceutical R&D—yet regulatory systems remain slow to catch up.

